These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37707573)

  • 1. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
    Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization.
    Xu JX; Qin SL; Wei HW; Chen YY; Peng YC; Qi LN
    Ann Med; 2023 Dec; 55(1):2199219. PubMed ID: 37070467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma.
    Jiang J; Hu H; Liu R; Wang JH; Long XR; Fan J; Yan ZP
    Medicine (Baltimore); 2017 Aug; 96(32):e7390. PubMed ID: 28796032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection.
    Liu F; Guo X; Dong W; Zhang W; Wei S; Zhang S; Zhu X; Zhou W; Zhang J; Liu H
    Int J Biol Sci; 2020; 16(16):3210-3220. PubMed ID: 33162826
    [No Abstract]   [Full Text] [Related]  

  • 5. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection.
    Jing CY; Fu YP; Zheng SS; Yi Y; Shen HJ; Huang JL; Xu X; Lin JJ; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Medicine (Baltimore); 2017 Mar; 96(11):e6140. PubMed ID: 28296727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
    Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
    Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new prognostic model predicting hepatocellular carcinoma early recurrence in patients with microvascular invasion who received postoperative adjuvant transcatheter arterial chemoembolization.
    Mao S; Shan Y; Yu X; Huang J; Fang J; Wang M; Fan R; Wu S; Lu C
    Eur J Surg Oncol; 2023 Jan; 49(1):129-136. PubMed ID: 36031472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
    Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
    Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
    He CB; Lao XM; Lin XJ
    Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms to evaluate the survival outcome of HCC patients undergoing selective postoperative adjuvant TACE.
    He Y; Qian J; Zhu G; Wu Z; Cui L; Tu S; Luo L; Shan R; Liu L; Shen W; Li Y; He K
    Radiol Med; 2024 Apr; 129(4):653-664. PubMed ID: 38512609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
    Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
    Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
    Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study.
    Lu N; Sheng S; Xiong Y; Zhao C; Qiao W; Ding X; Chen J; Zhang Y
    Front Immunol; 2024; 15():1459740. PubMed ID: 39315112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
    Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Lin HC; Huo TI
    Ann Surg Oncol; 2016 Mar; 23(3):994-1002. PubMed ID: 26487000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
    Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
    Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning-based model for predicting tumor recurrence after interventional therapy in HBV-related hepatocellular carcinoma patients with low preoperative platelet-albumin-bilirubin score.
    Wang Q; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1409443. PubMed ID: 38863693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
    Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
    Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.